MORRIS PLAINS, N.J., Jan. 6, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, will present a corporate overview, including comments on the Company’s product portfolio, at the 28th Annual J.P. Morgan Healthcare Conference to be held in San Francisco, CA. The presentation, scheduled for Thursday, January 14th at 1:30 p.m. (Pacific Time), can be downloaded simultaneously at http://www.immunomedics.com/1aboutus/present.pdf.
